ocular immunology
Cirrus Therapeutics Raises $11M to Advance Gene Therapy Targeting Dry Age-Related Macular Degeneration
Cirrus Therapeutics; gene therapy; dry AMD; IRAK-M; AAV; seed funding; ocular immunology; vision loss
Actionable Insights Powered by AI
Cirrus Therapeutics; gene therapy; dry AMD; IRAK-M; AAV; seed funding; ocular immunology; vision loss